FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019102023> ?p ?o ?g. }

• W2019102023 endingPage "714" @default.
• W2019102023 startingPage "695" @default.
• W2019102023 abstract "Both inpatient and outpatient treatment centers that focus solely on psychosocial therapies for the treatment of alcohol dependence have high relapse rates. Thus, extensive research has focused on the development of pharmacologic moieties to attenuate the craving for alcohol after acute alcohol detoxification. Three drug therapies are currently approved by the US Food and Drug Administration (FDA) for this purpose: disulfiram, naltrexone, and acamprosate. The latter was approved by the FDA in 2004.This article describes the pharmacologic properties and clinical usefulness of acamprosate for the treatment of alcohol dependence.Relevant information was identified through searches of MEDLINE (1966 to March 2005), International Pharmaceutical Abstracts (1970-2005), Current Contents (1996-2005), and Cumulative Index to Nursing and Allied Health Literature (1982-Week 2, 2004) using the key words acamprosate, alcohol dependence, and alcoholism (MeSH).Acamprosate limited to randomized, controlled clinical trials yielded 33 hits in MEDLINE. Twenty-two articles were reviewed for efficacy end points, and 10 were reviewed for pharmacology and pharmacokinetics data. Acamprosate plus pharmacokinetics and pharmacodynamics yielded 19 hits, some of which were duplicates from the previously described search. Acamprosate plus meta-analysis (MeSH) yielded 5 hits, naltrexone plus meta-analysis (MeSH) yielded 9 hits, and disulfiram plus meta-analysis yielded 3 hits. The most recent review articles and their reference lists were assessed to ensure completeness of literature searches. Based on these searches, acamprosate is known to be an analogue of taurine and gamma-aminobutyric acid (GABA), 2 central nervous system neuromodulators. Acamprosate is thought to share some of the cellular actions of taurine affecting GABA and glutaminergic receptors in the nucleus accumbens, a brain region that may be responsible for the reinforcing effects received after alcohol consumption. Acamprosate is thought to also suppress excitation-induced calcium entry that results from chronic alcohol exposure, thereby altering the conformation of the N-methyl-d-aspartate receptors. The percentage of patients taking acamprosate who were completely abstinent throughout the different durations of the studies varied from approximately 18% to 61%, compared with 4% to 45% with placebo. Diarrhea was the most common adverse effect accompanying acamprosate therapy, and this was generally described as dose related and transient.Acamprosate is associated with modest treatment effects. Its efficacy is similar to naltrexone, and the combination of acamprosate and naltrexone appears to be more efficacious than acamprosate alone, when combined with psychosocial interventions." @default.
• W2019102023 created "2016-06-24" @default.
• W2019102023 creator A5041035348 @default.
• W2019102023 creator A5048669748 @default.
• W2019102023 date "2005-06-01" @default.
• W2019102023 modified "2023-09-23" @default.
• W2019102023 title "Acamprosate for the treatment of alcohol dependence" @default.
• W2019102023 cites W1511524925 @default.
• W2019102023 cites W155898032 @default.
• W2019102023 cites W1839496149 @default.
• W2019102023 cites W1967123738 @default.
• W2019102023 cites W1969863800 @default.
• W2019102023 cites W1972659523 @default.
• W2019102023 cites W1973469222 @default.
• W2019102023 cites W1976345098 @default.
• W2019102023 cites W1979794009 @default.
• W2019102023 cites W1982903386 @default.
• W2019102023 cites W1983889922 @default.
• W2019102023 cites W1984609489 @default.
• W2019102023 cites W1991909661 @default.
• W2019102023 cites W1996025460 @default.
• W2019102023 cites W2001505545 @default.
• W2019102023 cites W2003542395 @default.
• W2019102023 cites W2006251242 @default.
• W2019102023 cites W2006777595 @default.
• W2019102023 cites W2007997117 @default.
• W2019102023 cites W2011830495 @default.
• W2019102023 cites W2014708765 @default.
• W2019102023 cites W2015741493 @default.
• W2019102023 cites W2017819433 @default.
• W2019102023 cites W2037199885 @default.
• W2019102023 cites W2039993999 @default.
• W2019102023 cites W2043821740 @default.
• W2019102023 cites W2043838228 @default.
• W2019102023 cites W2048536453 @default.
• W2019102023 cites W2051313298 @default.
• W2019102023 cites W2052363428 @default.
• W2019102023 cites W2052450056 @default.
• W2019102023 cites W2054992104 @default.
• W2019102023 cites W2056671158 @default.
• W2019102023 cites W2056797993 @default.
• W2019102023 cites W2057415848 @default.
• W2019102023 cites W2059402504 @default.
• W2019102023 cites W2060198298 @default.
• W2019102023 cites W2060329826 @default.
• W2019102023 cites W2063479428 @default.
• W2019102023 cites W2066698603 @default.
• W2019102023 cites W2072098467 @default.
• W2019102023 cites W2083069793 @default.
• W2019102023 cites W2084343967 @default.
• W2019102023 cites W2086730289 @default.
• W2019102023 cites W2089223750 @default.
• W2019102023 cites W2095419965 @default.
• W2019102023 cites W2098785223 @default.
• W2019102023 cites W2099195029 @default.
• W2019102023 cites W2099737019 @default.
• W2019102023 cites W2100702853 @default.
• W2019102023 cites W2108740579 @default.
• W2019102023 cites W2108974311 @default.
• W2019102023 cites W2120013037 @default.
• W2019102023 cites W2121951622 @default.
• W2019102023 cites W2125230596 @default.
• W2019102023 cites W2125435699 @default.
• W2019102023 cites W2126519871 @default.
• W2019102023 cites W2135966256 @default.
• W2019102023 cites W2136699488 @default.
• W2019102023 cites W2145441321 @default.
• W2019102023 cites W2147784083 @default.
• W2019102023 cites W2151008578 @default.
• W2019102023 cites W2152170602 @default.
• W2019102023 cites W2157113531 @default.
• W2019102023 cites W2161761640 @default.
• W2019102023 cites W2162917678 @default.
• W2019102023 cites W2171727981 @default.
• W2019102023 cites W2287520975 @default.
• W2019102023 cites W2470593938 @default.
• W2019102023 cites W2915165123 @default.
• W2019102023 cites W3027683458 @default.
• W2019102023 cites W4206393415 @default.
• W2019102023 cites W4230396476 @default.
• W2019102023 cites W4235354968 @default.
• W2019102023 cites W4255226930 @default.
• W2019102023 cites W4256253687 @default.
• W2019102023 cites W4323238831 @default.
• W2019102023 cites W4375795973 @default.
• W2019102023 doi "https://doi.org/10.1016/j.clinthera.2005.06.015" @default.
• W2019102023 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16117977" @default.
• W2019102023 hasPublicationYear "2005" @default.
• W2019102023 type Work @default.
• W2019102023 sameAs 2019102023 @default.
• W2019102023 citedByCount "119" @default.
• W2019102023 countsByYear W20191020232012 @default.
• W2019102023 countsByYear W20191020232013 @default.
• W2019102023 countsByYear W20191020232014 @default.
• W2019102023 countsByYear W20191020232015 @default.
• W2019102023 countsByYear W20191020232016 @default.
• W2019102023 countsByYear W20191020232017 @default.
• W2019102023 countsByYear W20191020232018 @default.

• next